II. Indications
III. Efficacy
- Most common surgery for Benign Prostatic Hyperplasia
- Reduces symptoms in 88% of patients
IV. Complications
- Initial adverse effects
- Blood loss requiring transfusion: 1%
- Mortality: 0.2% (as high as 10% if age over 80 years)
- Postoperative Urinary Tract Infection: 5 to 10%
- Longterm adverse effects
- Unsatisfactory longterm outcome
- Inadequate relief of BPH symptoms: 20-25%
- Reoperation rate within 10 years: 15 to 20%
- Impotence: 5-10% (evaluate potency prior to TURP)
- Retrograde ejaculation: 70 to 75%
- Urinary Incontinence: 2 to 4%
- Unsatisfactory longterm outcome
V. References
- Cooner (1994) Prostate Disease, AAFP, p. 9-15
- Dull (2002) Am Fam Physician 66(1): 77-84 [PubMed]
- Oesterling (1995) N Engl J Med 332(2):99-109 [PubMed]